Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04341740 · ClinicalTrials.gov registry record · NA
Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma
A NA study, sponsored by University of Oklahoma.
- Terminated
- Registry status
- NA
- Development phase
- 6
- Enrollment target
NCT04341740 is a NA study that was terminated before completion, run by University of Oklahoma. The registered enrollment target is 6 participants.
The verdict
NCT04341740, a NA study, was terminated before completion, sponsored by University of Oklahoma.
- TERMINATED
- Registry status
- NA
- Development phase
- 6 participants
- Enrollment target
Study Summary
The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.
Interventions
- PROCEDURE Bone Marrow Aspirate
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2021-04-09 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04341740
The ClinicalTrials.gov registry entry for NCT04341740 describes a study currently listed as terminated, categorized as NA. The registered enrollment target is 6 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Oklahoma, which has 358 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Bone Marrow Aspirate is the first listed.
NCT04341740 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04341740 about?
NCT04341740 is a clinical study titled "Investigating Marrow Infiltrating Lymphocytes in Renal Cell Carcinoma". The purpose of this research is to collect health-related information as well as bone marrow and blood specimens to determine if a new form of treatment for patients with kidney and bladder cancer may be possible.
What is the current status of trial NCT04341740?
This trial is currently terminated. It is a NA study. The enrollment target is 6 participants. The study started on 2020-07-22. Estimated completion is 2021-04-09.
What interventions are being tested in trial NCT04341740?
The interventions under investigation include: Bone Marrow Aspirate (PROCEDURE).
Who is sponsoring clinical trial NCT04341740?
This trial is sponsored by University of Oklahoma, which has 358 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.